SynthesisBMC pediatrics2026
Pediatric Clostridium septicum infections: a systematic review and case-based perspective.
Synthesis in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextPediatric Clostridium septicum infections are extremely rare but often fulminant and rapidly progressive. They may manifest as clostridial myonecrosis, sepsis, or with gastrointestinal involvement. Systematic data on presentation, management, and outcomes remain scarce.
objectiveTo systematically review published pediatric cases of C. septicum infection, focusing on clinical presentation, underlying conditions, management, and outcome as an update to the review by Smith-Slatas et al. (2006). In particular, to assess how frequently gastrointestinal involvement occurs in this disease and whether its presence is associated with poorer outcomes. Furthermore, to highlight the diagnostic challenges and therapeutic urgency of this condition through a fatal case. DATA SOURCES: PubMed, Scopus, Web of Science, and the Cochrane Library were searched for reports from May 2006 to May 2025. STUDY SELECTION: Studies describing patients under 18 years with confirmed C. septicum infection were included. DATA EXTRACTION: Variables included infection site, underlying disease, treatment, and outcome. A previously unpublished fatal case of pediatric clostridial myonecrosis with ileocolic intussusception was added. Fisher's exact test was used for statistical analysis.
resultsOnly 18 pediatric cases published since 2006 were found; 44% had clostridial myonecrosis and 50% gastrointestinal involvement. STEC-HUS occurred in 50%. Compared with a 2006 review, rates of STEC-HUS, surgical intervention, overall survival, and absence of gastrointestinal involvement have increased. Surgical debridement was strongly associated with survival (p < 0.01), whereas gastrointestinal involvement was associated with fatal outcome (p = 0.014). The reported child deteriorated rapidly after initial intussusception diagnosis and died despite maximal intensive care. LIMITATIONS: Very few cases are available because the disease is exceptionally rare; the analysis is retrospective.
conclusionsSurgical source control is associated with improved survival. Gastrointestinal involvement is a major risk factor for poor outcome and may include intussusception.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.